Compare Duke Energy Corp (DUK) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

Duke Energy CorpTrade

Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Duke Energy Corp vs Neurocrine Biosciences Inc — how do they compare? Duke Energy Corp trades at $122.8 (market cap $94.49B), while Neurocrine Biosciences Inc trades at $154.01 (market cap $16.76B). The key difference: Duke Energy Corp is far larger — about 5.6× Neurocrine Biosciences Inc's market cap, and Duke Energy Corp pays a 3.58% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.

	DUK	NBIX
Market Cap	$94.49B	$16.76B
Sector	Utilities	Health
52-Week High	$133.46	$185.50
52-Week Low	$113.99	$123.10
Enterprise Value	$187.00B	$16.78B
Dividend Yield	3.58%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Duke Energy Corp

No Aura AI signal available yet.

Neurocrine Biosciences Inc

Neurocrine Biosciences (NBIX) trades at $163.41, up 2.25% today, with a bearish technical signal but strong fundamentals including a 39% revenue growth in Q2 2026 and a net income margin of 20.91%. Recent news highlights Phase 1 trial initiation for a GLP-1/GIP/glucagon receptor agonist and leadership appointments, supporting growth prospects.

The outlook is positive with an analyst consensus price target of $208.82, implying 28% upside, driven by robust earnings beats and pipeline advancements. Risks include clinical trial outcomes and competitive pressures in biopharma, but institutional buying and high analyst buy ratings (86.49%) reflect confidence in execution.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DUK

Severe storms cut power to 160,000 Duke Energy customers in Greater Cincinnati, restoration ongoing.PRNewsWire · 11 hours agoBearish Call 811 before digging to prevent nearly 4,500 utility line damages reported in 2026 so far.PRNewsWire · 22 hours agoNeutral Duke Energy prices $1.75B equity units offering to fund debt redemption and corporate needsPRNewsWire · 1 day agoNeutral View details →

NBIX

Neurocrine starts Phase 1 trial for new obesity drug NBIP-'1968 targeting multiple metabolic pathways.PRNewsWire · 5 days agoBullish View details →

About Duke Energy Corp

Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.